Public trial registry of the CCC-Munich

Trial APHINITY (BO25126)

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
APHINITY (BO25126)
World
Full title
:

A randomized multicenter, double-blind, placebo-controlled comparison of chemotherapy plus trastuzumab plus placebo versus chemotherapy plus trastuzumab plus pertuzumab as adjuvant therapy in patients with operable HER2-positive primary breast cancer

World
Responsible organization
:
Frauenklinik Frauenklinik Ismaninger Str. 22 81675 München Germany
Indications
Classification Code Description
- Breastcancer
Trial design
World
Phase
:
III
Status
World
Status
:
Recruitment finished
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Chemo - Therapieart: adjuvant

Participants
Function Prename Surname Organization
World Responsible contact Johannes Ettl Frauenklinik Frauenklinik Ismaninger Str. 22 81675 München Germany Magnifier